Yuliang Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yuliang Wang has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
Tao Liu
National Health Commission's Key Laboratory for Critical Care Medicine, Tianjin First Central Hospital, Tianjin 300071, China
4 shared publicationsXiaobo Chen
Union Stem and Gene Engineering Co., Ltd., Tianjin 300384, China
4 shared publicationsYanyan Zhang
Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS 1170, CNRS GDR 3697 Micronit, 94805 Villejuif, France; Institut Gustave Roussy, Univ Paris-Sud, Université Paris Saclay, 94805 Villejuif, France
3 shared publicationsFeng Wang
Department of Genetics, School of Basic Medical Sciences Tianjin Medical University Tianjin China
2 shared publicationsJ. Geng
Department of Clinical Laboratory, 2nd Hospital of Tianjin Medical University, Tianjin, P.R. China
2 shared publicationsJun-Feng Wang
Department of Colorectal Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China
2 shared publications
Latest Publications
- Open Access
- 1 February 2026
- Published by Wolters Kluwer Health in Journal of Family Medicine and Primary Care
- Vol. 15 (2) , 955-960
Comparing routine hematological parameters on COVID-19, bacterial infections, and coinfection in elderly severe community-acquired pneumonia, a retrospective study in primary hospitals
A BSTRACT: Objective: This study aimed to compare the differences in routine hematological parameters upon admission in elderly patients with severe community-acquired pneumonia (CAP) caused by COVID-19, bacterial infections, and coinfection. Methods: A retrospective study was conducted on elderly patients with severe CAP caused by COVID-19, bacterial infections, and coinfection. Routine laboratory hematological parameters were compared. Results: Pairwise comparisons revealed that LY and MY counts and PT levels were the highest in the bacteria group, while Mg levels were the lowest in the COVID-19 group, and IL-6 levels were the lowest in the coinfection group. WBC counts, Ca, and P levels were higher in the bacteria group than in the COVID-19 group, and APTT and ALB levels were significantly elevated in the bacteria group compared to the coinfection group. Fe levels were lower in the coinfection group than in the COVID-19 group. Conclusion: Our results indicate that in elderly patients, these hematological parameters are associated with severe CAP of different etiologies and can aid in diagnosis, along with clinical signs, as part of clinical prediction rules.
- 1 February 2026
- Published by Wolters Kluwer Health in Journal of Family Medicine and Primary Care
- Vol. 15 (2) , 955-960
Open AccessComparing routine hematological parameters on COVID-19, bacterial infections, and coinfection in elderly severe community-acquired pneumonia, a retrospective study in primary hospitals
A BSTRACT: Objective: This study aimed to compare the differences in routine hematological parameters upon admission in elderly patients with severe community-acquired pneumonia (CAP) caused by COVID-19, bacterial infections, and coinfection. Methods: A retrospective study was conducted on elderly patients with severe CAP caused by COVID-19, bacterial infections, and coinfection. Routine laboratory hematological parameters were compared. Results: Pairwise comparisons revealed that LY and MY counts and PT levels were the highest in the bacteria group, while Mg levels were the lowest in the COVID-19 group, and IL-6 levels were the lowest in the coinfection group. WBC counts, Ca, and P levels were higher in the bacteria group than in the COVID-19 group, and APTT and ALB levels were significantly elevated in the bacteria group compared to the coinfection group. Fe levels were lower in the coinfection group than in the COVID-19 group. Conclusion: Our results indicate that in elderly patients, these hematological parameters are associated with severe CAP of different etiologies and can aid in diagnosis, along with clinical signs, as part of clinical prediction rules.
- Open Access
- 15 May 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Oncology
- Vol. 17 (5) , 104591
Natural killer cell dysfunction is associated with colorectal cancer with severe COVID-19
BACKGROUND Severe acute respiratory syndrome coronavirus 2 induced coronavirus disease 2019 (COVID-19) has posed a great challenge to public health worldwide and also increased susceptibility to colorectal cancer (CRC). Natural killer (NK) cells serve as the first line of defense in the host’s innate immune system, performing natural killing functions and mediating cytotoxicity against tumors and viruses. Therefore, a better understanding of NK cell cytotoxicity may facilitate the development of treatment strategies for CRC-associated with COVID-19. AIM To investigate the cytotoxic killing function of peripheral NK cells in patients with CRC and severe COVID-19 (CRC+ patients). METHODS The percentages of circulating NK and NKT cells in CRC+ and age-matched patients with CRC were analyzed using flow cytometry. NK cell cytotoxic activity (NKCA) and corresponding NK cytotoxic factor (NKCF) activity in peripheral blood mononuclear cells were evaluated using a Real-Time Cell Analyzer. RESULTS The numbers and percentage of peripheral NK and NKT cells in patients with CRC+ were lower than those in patients with CRC. Additionally, compared to patients with CRC, those with CRC+ had lower levels of NKCA and NKCF activity in lysed K562 cells. Positive correlations were observed between NKCA and NK cell numbers, NKCA and NK cell percentages, NKCF activity, and NK cell percentages in patients with CRC+. Furthermore, a negative correlation was observed between NKCA and the severity of COVID-19 in patients with CRC. The area under the receiver operating characteristic curve for NKCA was greater than those for the other indices. CONCLUSION CRC+ is associated with lower levels of peripheral NK cells and impaired natural cytotoxicity, contributing to the immunopathogenesis of severe COVID-19 rather than immune control.
- 15 May 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Oncology
- Vol. 17 (5) , 104591
Open AccessNatural killer cell dysfunction is associated with colorectal cancer with severe COVID-19
BACKGROUND Severe acute respiratory syndrome coronavirus 2 induced coronavirus disease 2019 (COVID-19) has posed a great challenge to public health worldwide and also increased susceptibility to colorectal cancer (CRC). Natural killer (NK) cells serve as the first line of defense in the host’s innate immune system, performing natural killing functions and mediating cytotoxicity against tumors and viruses. Therefore, a better understanding of NK cell cytotoxicity may facilitate the development of treatment strategies for CRC-associated with COVID-19. AIM To investigate the cytotoxic killing function of peripheral NK cells in patients with CRC and severe COVID-19 (CRC+ patients). METHODS The percentages of circulating NK and NKT cells in CRC+ and age-matched patients with CRC were analyzed using flow cytometry. NK cell cytotoxic activity (NKCA) and corresponding NK cytotoxic factor (NKCF) activity in peripheral blood mononuclear cells were evaluated using a Real-Time Cell Analyzer. RESULTS The numbers and percentage of peripheral NK and NKT cells in patients with CRC+ were lower than those in patients with CRC. Additionally, compared to patients with CRC, those with CRC+ had lower levels of NKCA and NKCF activity in lysed K562 cells. Positive correlations were observed between NKCA and NK cell numbers, NKCA and NK cell percentages, NKCF activity, and NK cell percentages in patients with CRC+. Furthermore, a negative correlation was observed between NKCA and the severity of COVID-19 in patients with CRC. The area under the receiver operating characteristic curve for NKCA was greater than those for the other indices. CONCLUSION CRC+ is associated with lower levels of peripheral NK cells and impaired natural cytotoxicity, contributing to the immunopathogenesis of severe COVID-19 rather than immune control.
- Open Access
- 15 May 2024
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Oncology
- Vol. 16 (5) , 2113-2122
Immunomodulation of adipose-derived mesenchymal stem cells on peripheral blood mononuclear cells in colorectal cancer patients with COVID-19
Immunomodulation of adipose-derived mesenchymal stem cells on peripheral blood mononuclear cells in colorectal cancer patients with COVID-19
- 15 May 2024
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Oncology
- Vol. 16 (5) , 2113-2122
Open AccessImmunomodulation of adipose-derived mesenchymal stem cells on peripheral blood mononuclear cells in colorectal cancer patients with COVID-19
Immunomodulation of adipose-derived mesenchymal stem cells on peripheral blood mononuclear cells in colorectal cancer patients with COVID-19
- Open Access
- 25 November 2023
- Published by Elsevier in Immunobiology
- Vol. 228 (6) , 152765
Adipose tissue-derived mesenchymal stromal cells attenuate acute lung injury induced by trauma and haemorrhagic shock
- 25 November 2023
- Published by Elsevier in Immunobiology
- Vol. 228 (6) , 152765
Open AccessAdipose tissue-derived mesenchymal stromal cells attenuate acute lung injury induced by trauma and haemorrhagic shock
- Open Access
- 7 November 2022
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 10 (12) , e733
Emergence of SARS‐CoV‐2 Omicron variant and strategies for tackling the infection
Introduction: Nowadays, emerging SARS‐CoV‐2 Omicron, the novel highly mutated VOC, has quickly spread as the dominant variant in over 190 countries worldwide through the first part of 2022, which is influencing the infectivity, transmissibility, pathogenicity, and severity of COVID‐19 pandemic. Additionally, clinical cases and experimental studies have reported that Omicron variant likely leads to weakened immune protection elicited by infection, antibody therapies, and vaccines. The new wave, from late February, 2022, was escalated abruptly by higher levels of transmission of Omicron BA.2 sublineage in China.Methods and Results: Following a systematic database search, this review summarizes the salient features of Omicron sublineages, and their impact on transmissibility, disease severity as well as the efficacy of the available vaccines and treatment against the Omicron.Conclusion: We hope this study will provide a scientific reference for alleviating the burden of COVID‐19.
- 7 November 2022
- Published by Wiley in Immunity, Inflammation and Disease
- Vol. 10 (12) , e733
Open AccessEmergence of SARS‐CoV‐2 Omicron variant and strategies for tackling the infection
Introduction: Nowadays, emerging SARS‐CoV‐2 Omicron, the novel highly mutated VOC, has quickly spread as the dominant variant in over 190 countries worldwide through the first part of 2022, which is influencing the infectivity, transmissibility, pathogenicity, and severity of COVID‐19 pandemic. Additionally, clinical cases and experimental studies have reported that Omicron variant likely leads to weakened immune protection elicited by infection, antibody therapies, and vaccines. The new wave, from late February, 2022, was escalated abruptly by higher levels of transmission of Omicron BA.2 sublineage in China.Methods and Results: Following a systematic database search, this review summarizes the salient features of Omicron sublineages, and their impact on transmissibility, disease severity as well as the efficacy of the available vaccines and treatment against the Omicron.Conclusion: We hope this study will provide a scientific reference for alleviating the burden of COVID‐19.
- 1 February 2021
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 170 (4) , 485-488
Expression and Clinical Significance of OX40 and OX40L mRNA in Hepatocellular Carcinoma
In a retrospective study, the expression of mRNA of membrane receptor OX40 and its ligand OX40L in liver tissues was analyzed in 34 patients with hepatocellular carcinoma in order to assess their clinical implications and prognostic value. Expression of mRNA was analyzed by reverse transcription PCR and TaqMan probes. Expression of OX40 mRNA was significantly higher in tumor specimens in paired comparison with the samples of adjacent non-tumor tissue or normal liver tissue of control patients. In contrast, expression of OX40L mRNA was lower in tumor tissue in paired comparison with the samples of adjacent non-tumor tissue or normal liver tissue. The clinical and pathological analysis showed that expression of OX40 mRNA significantly correlated with the degree of tumor differentiation; there was an insignificant decreasing trend in the length of recurrence-free period. It was hypothesized that microenvironment of hepatocellular carcinoma can induce immunosuppression due to dysregulation of the expression of OX40 and OX40L in tumor tissue, which promotes tumor growth.
- 1 February 2021
- Published by Springer Nature in Bulletin of Experimental Biology and Medicine
- Vol. 170 (4) , 485-488
Expression and Clinical Significance of OX40 and OX40L mRNA in Hepatocellular Carcinoma
In a retrospective study, the expression of mRNA of membrane receptor OX40 and its ligand OX40L in liver tissues was analyzed in 34 patients with hepatocellular carcinoma in order to assess their clinical implications and prognostic value. Expression of mRNA was analyzed by reverse transcription PCR and TaqMan probes. Expression of OX40 mRNA was significantly higher in tumor specimens in paired comparison with the samples of adjacent non-tumor tissue or normal liver tissue of control patients. In contrast, expression of OX40L mRNA was lower in tumor tissue in paired comparison with the samples of adjacent non-tumor tissue or normal liver tissue. The clinical and pathological analysis showed that expression of OX40 mRNA significantly correlated with the degree of tumor differentiation; there was an insignificant decreasing trend in the length of recurrence-free period. It was hypothesized that microenvironment of hepatocellular carcinoma can induce immunosuppression due to dysregulation of the expression of OX40 and OX40L in tumor tissue, which promotes tumor growth.
- 15 September 2020
- Published by Oxford University Press (OUP) in Laboratory Medicine
- Vol. 52 (1) , 10-15
Thrombocytopenia Is Associated with COVID-19 Severity and Outcome: An Updated Meta-Analysis of 5637 Patients with Multiple Outcomes
The COVID-19 pandemic is persistent worldwide. A prior meta-analysis suggested the association of thrombocytopenia (TCP) with more severe COVID-19 illness and high mortality. Considering newly published studies, we updated the previous meta-analysis to confirm and explain the association of TCP with COVID-19 severity and multiple outcomes. Twenty-four studies with 5637 patients with COVID-19 were included in this study. The weighted incidence of TCP in COVID-19 was 12.4% (95% confidence interval [CI], 7.9%–17.7%). Data synthesis showed that the platelet number was lower in patients with either more severe illness or poor outcomes and even lower in nonsurvivors, with weighted mean differences of −24.56 × 109/L, −22.48 × 109/L, and −49.02 × 109/L, respectively. The meta-analysis of binary outcomes (with and without TCP) indicated the association between TCP and 3-fold enhanced risk of a composite outcome of intensive care unit admission, progression to acute respiratory distress syndrome, and mortality (odds ratio [OR], 3.49; 95% CI, 1.57–7.78). Subgroup analysis by endpoint events suggested TCP to be significantly associated with mortality (OR, 7.37; 95% CI, 2.08–26.14). Overall, the present comprehensive meta-analysis indicated that approximately 12% of hospitalized patients with COVID-19 have TCP, which also represents a sign of more severe illness and poor outcomes.
- 15 September 2020
- Published by Oxford University Press (OUP) in Laboratory Medicine
- Vol. 52 (1) , 10-15
Thrombocytopenia Is Associated with COVID-19 Severity and Outcome: An Updated Meta-Analysis of 5637 Patients with Multiple Outcomes
The COVID-19 pandemic is persistent worldwide. A prior meta-analysis suggested the association of thrombocytopenia (TCP) with more severe COVID-19 illness and high mortality. Considering newly published studies, we updated the previous meta-analysis to confirm and explain the association of TCP with COVID-19 severity and multiple outcomes. Twenty-four studies with 5637 patients with COVID-19 were included in this study. The weighted incidence of TCP in COVID-19 was 12.4% (95% confidence interval [CI], 7.9%–17.7%). Data synthesis showed that the platelet number was lower in patients with either more severe illness or poor outcomes and even lower in nonsurvivors, with weighted mean differences of −24.56 × 109/L, −22.48 × 109/L, and −49.02 × 109/L, respectively. The meta-analysis of binary outcomes (with and without TCP) indicated the association between TCP and 3-fold enhanced risk of a composite outcome of intensive care unit admission, progression to acute respiratory distress syndrome, and mortality (odds ratio [OR], 3.49; 95% CI, 1.57–7.78). Subgroup analysis by endpoint events suggested TCP to be significantly associated with mortality (OR, 7.37; 95% CI, 2.08–26.14). Overall, the present comprehensive meta-analysis indicated that approximately 12% of hospitalized patients with COVID-19 have TCP, which also represents a sign of more severe illness and poor outcomes.
- 1 January 2020
- Published by Publishing House RAMS in Bulletin of Experimental Biology and Medicine
- Vol. 170 (10)
Expression and clinical implications of mRNA encoding membrane proteins OX40 and OX40L in hepatocellular carcinoma
- 1 January 2020
- Published by Publishing House RAMS in Bulletin of Experimental Biology and Medicine
- Vol. 170 (10)
Expression and clinical implications of mRNA encoding membrane proteins OX40 and OX40L in hepatocellular carcinoma
- 1 December 2019
- Published by Elsevier in Transplantation Proceedings
- Vol. 51 (10) , 3364-3368
Hepatitis B Virus cccDNA in Hepatocellular Carcinoma Tissue Increases the Risk of Recurrence After Liver Transplantation
- 1 December 2019
- Published by Elsevier in Transplantation Proceedings
- Vol. 51 (10) , 3364-3368
Hepatitis B Virus cccDNA in Hepatocellular Carcinoma Tissue Increases the Risk of Recurrence After Liver Transplantation